[ Price : $8.95]
Federal Register Notice: FDA releases additional product-specific bioequivalence recommendations.[ Price : $8.95]
Federal Register Notice: FDA seeks comments on collections of information associated with Clinical Laboratory Improvement Amendmen...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on the use of the FDA Electronic Submission Gateway and the Safety Reporting Portal to...[ Price : $8.95]
Proteonomix, Inc. and University of Medicine and Dentistry of New Jersey agree to conduct a Phase 1 clinical trial to study the fi...[ Price : $8.95]
Federal Register Final rule: FDA amends the animal drug regulations to reflect a change of sponsor for 3 ANADAs to Phibro Animal H...[ Price : $8.95]
A survey by the Alliance for Safe Biologic Medicines indicates that physicians would like to see distinct names for approved biosi...[ Price : $8.95]
Members of FDAs Cardiovascular and Renal Drugs Advisory Committee say that Cornerstones NDA for lixivaptan should not be approved....[ Price : $8.95]
FDA consumer safety officer Brooke Higgins tells a conference session that FDA investigators are spending more time during drug pr...